Table 1—

Baseline characteristics

Screened cohort
Analyzed subjects
Type 1Type 2NondiabeticAllType 1Type 2NondiabeticAll
n3352369066126815980507
Age42 ± 13.154 ± 9.438 ± 13.146.1 ± 13.543 ± 1356 ± 940 ± 1446 ± 14
Sex (% female)171 (51)119 (50)60 (67)350 (53)140 (52)81 (51)55 (69)276 (54)
Race/ethnicity
    Non-Hispanic white282 (84)145 (61)60 (67)487 (74)248 (93)118 (73)56 (71)422 (83)
    African/African American23 (7)59 (25)15 (17)97 (15)5 (2)21 (13)12 (15)38 (8)
    Hispanic18 (5)23 (10)15 (17)56 (8)15 (6)12 (8)12 (15)39 (8)
    Other12 (4)9 (4)021 (3)08 (5)08 (2)
Smoking status40 (12)29 (12)7 (8)76 (12)32 (12)14 (9)7 (9)53 (11)
A1C (%)7.3 ± 1.16.7 ± 0.95.3 ± 0.36.8 ± 1.27.3 ± 1.16.8 ± 1.15.2 ± 0.36.8 ± 1.3
Treatment
    External pump42%47%
    Three or more daily injections58%53%
    Diet only12%10%
    Oral agent(s) only54%52%
    Insulin only17%19%
    Insulin + oral agent(s)17%19%
  • Data are means ± SD or n (%) unless otherwise indicated.